Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ABCIXIMAB
- Platelet Function in Patients With Ischemic Stroke Treated With Anti-thrombotic or Thrombolytic
- Effect of Upstream High Bolus Dose of Tirofiban in Primary PCI for the Patients With STEMI on Short Term Outcome
- Full Dose Tenecteplase (TNK-tPA) Together With Heparin Sodium, Full Dose Tenecteplase With Enoxaparin, Half Dose Tenecteplase Together With Abciximab and Heparin Sodium in Patients With Acute Myocardial Infarction (AMI)
- A Randomized Trial of Intracoronary Reopro to Improve Coronary Microvascular Function
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- Thrombectomy Under Reopro Versus Alteplase to Treat Stoke
- Abciximab (ReoPro) as a Therapeutic Intervention for Sickle Cell Vaso-Occlusive Pain Crisis
- Clinical Effects of Eptifibatide Administration in High Risk Patients Presenting With Non-ST Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Urgent Coronary Artery Bypass Graft Surgery in Short- and Long-Term Follow-up
- Anti-inflammatory Effects of Intracoronary and Intravenous Abciximab Administration During Primary Percutaneous Coronary Intervention
- Randomized Trial of Standard vs ClearWay-infused Abciximab and Thrombectomy for Myocardial Infarction
- Tailored Antiplatelet Therapy During Percutaneous Coronary Intervention in Patients With Diabetes Mellitus
- Efficacy of Combination of IntraCoronary Bolus Abciximab and Aspiration Thrombectomy in STEMI
- Early Thienopyridine Treatment to Improve Primary PCI in Patients With Acute MI
- Bivalirudin/Prasugrel Versus Abciximab/Clopidogrel in Patients Presenting With STEMI
- Aspirin Resistance and Percutaneous Coronary Intervention (PCI)
- Intracoronary Bolus Only Compared With Intravenous Bolus and 12-hours Infusion of Abciximab in Non-ST Elevation Myocardial Infarction.
- Comparison of Drug Eluting and Bare Metal Stents With or Without Abciximab in ST Elevation Myocardial Infarction
- The INFUSE - Anterior Myocardial Infarction (AMI) Study
- Efficacy of Abciximab Bolus Only Regimen in Providing Inhibition of Platelet Action Over Time
- Comparison of Intracoronary Versus Intravenous Abciximab in ST-segment Elevation Myocardial Infarction (CICERO)
- Intracoronary Abciximab With Clearway Catheter
- The STREAM Percutaneous Coronary Intervention Anticoagulant Sub-study
- Efficacy of Early Administration of Clotinab in Acute Myocardial Infarction
- Comparison Between Thrombolysis and Primary Percutaneous Coronary Intervention (PCI) to Treat ST-Segment Elevation Myocardial Infarction
- Reduced Dose of Unfractionated Heparin in Patients Undergoing PCI
- Abciximab i.v. Versus i.c. in ST-elevation Myocardial Infarction
- Intravenous Versus Intracoronary Use of Abciximab
- Myocardial Infarction With ST-Elevation
- THE REOPEN-AMI STUDY - Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction
- Safety of High-dose Tirofiban During Coronary Angioplasty
- Antithrombotic Regimens and Outcome
- A Randomized Trial of Early Discharge After Trans-radial Stenting of Coronary Arteries in Acute MI and Rescue-PCI
- A Randomized Trial of Early Discharge After Trans-radial Stenting of Coronary Arteries in Acute MI
- Efficacy Of Eptifibatide Compared To Abciximab In Primary Percutaneous Coronary Intervention (PCI) For Acute ST Elevation Myocardial Infarction (STEMI)
- Abciximab in Patients Undergoing Percutaneous Coronary Intervention for Cardiogenic Shock
- The Effects of Tirofiban in Diabetic Patients Undergoing Elective Percutaneous Coronary Intervention
- FATA: Randomized Study on Facilitated Angioplasty With Tirofiban or Abciximab
- Anti Ischemic Effects of Abciximab in Angioplasty and Stenting Patients
- PIoglitazone for PrEvention of Restenosis in Diabetic Patients
- Randomized Comparison of Abciximab Plus Heparin With Bivalirudin in Acute Coronary Syndrome
- Efficacy Study on Early Versus Late Abciximab Administration During Primary Coronary Angioplasty
- Half-Dose Intracoronary Abciximab Bolus Improves the Mortality Outcome Compared to Standard Intravenous Regimen
- Abciximab i.v. Versus i.c. in Primary PCI Patients With STEMI
- A Study Comparing the Efficacy and Safety of Intracoronary Stenting With or Without Abciximab, an Anti-Platelet Therapy, and Conventional Coronary Angioplasty With Abciximab
- A Study Evaluating the Efficacy and Safety of Abciximab, an Anti-Platelet Therapy, in Patients With Unstable Angina Not Responding to Standard Medical Therapy Who Are Eligible for Coronary Angioplasty
- A Study Evaluating the Efficacy and Safety of Abciximab, an Anti-platelet Therapy, in Patients Undergoing High-risk Coronary Angioplasty
- A Study Comparing the Efficacy and Safety of Abciximab, an Anti-Platelet Therapy, in Combination With Two Different Heparin Regimens in Patients Undergoing Percutaneous Coronary Intervention.
- Stroke Prevention With Abciximab in Carotid Endarterectomy
- EArly Discharge After Transradial Stenting of CoronarY Arteries: The EASY Study
- Abciximab in Wake-up Stroke
- Below Study - Balloonangioplasty or Stents With ReoPro for Prevention of Subacute Reocclusion in Arteries Below the Knee
- Value of Abciximab in Patients With AMI Undergoing Primary PCI After Clopidogrel Pretreatment (BRAVE 3)
- Abciximab, Clopidogrel and Percutaneous Coronary Intervention in Acute Coronary Syndrome (ISAR-REACT-2)
- Abciximab for Prevention of Stroke Recurrence Before Endarterectomy in Symptomatic Carotid Stenosis
- A Study of Effectiveness and Safety of Abciximab in Patients With Acute Ischemic Stroke (AbESTT-II)
- ReoPro and Retavase to Treat Acute Stroke
- A Study of Abciximab and Reteplase When Administered Prior to Catherization After a Myocardial Infarction (Finesse)
- ReoPro and Retavase to Restore Brain Blood Flow After Stroke
Clinical trials list
click for details